HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab

Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):e143-e146. doi: 10.1016/j.clml.2017.12.008. Epub 2018 Jan 3.
No abstract available

Keywords: Anti-PD-1; Autoimmune diabetes; Human immunodeficiency virus; Immune checkpoint inhibitor; Immune-related adverse event.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / therapeutic use
  • Drug Resistance, Neoplasm / drug effects*
  • HIV Infections / complications*
  • Hodgkin Disease / complications*
  • Hodgkin Disease / diagnostic imaging
  • Hodgkin Disease / drug therapy*
  • Humans
  • Male
  • Nivolumab / therapeutic use*
  • Positron Emission Tomography Computed Tomography / methods
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab